Drugs / BAY87-2243
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01297530 | Apr 2011 → Jul 2012 | neoplasm | Bayer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY87-2243 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01297530 ↗ |
| Route | Oral | “BAY87-2243 will be given per mouth” NCT01297530 ↗ |